神経補綴：各種技術と世界市場

世界の神経補綴 の市場規模は、2022年の50億米ドル、2023年の54億米ドルから、予測期間中は8.3％のCAGRで推移し、2028年には81億米ドルの規模に成長すると予測されています。

製品タイプ別では、人工内耳の部門が22022年の15億米ドル、2023年の16億米ドルから、5.2%のCAGRで推移し、2028年には21億米ドルの規模に成長すると予測されています。また、膀胱・腸管制御インプラントの部門は、2022年の9億6770万米ドル、2023年の11億米ドルから、11.6%のCAGRで推移し、2028年には19億米ドルの規模に成長すると予測されています。

当レポートでは、世界の神経補綴 の市場を調査し、市場および技術の概要、市場影響因子の分析、法規制環境、市場規模の推移・予測、各種区分・地域別の詳細分析、技術および特許の動向、ESGの展開、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 サマリー・ハイライト

第3章 市場概要

• 概要と定義
• 神経補綴
• 神経補綴 の必要性
• 神経補綴 のタイプ
• 人工内耳
• 運動回復のための神経補綴
• 脳深部刺激装置 (DBS)
• 膀胱・腸管制御インプラント
• 人工視覚
• 規制状況
• 米国
• 欧州

第4章 市場力学

• 促進要因
• 良好な人口動態動向
• 技術の進歩
• 規制当局によるサポート
• 高まるコスト削減圧力
• バイオ医療研究のための強固な資金調達環境
• 未浸透の市場
• 課題
• 高コスト
• 技術的課題
• 安全性の懸念
• プライバシーと説明責任に関する懸念
• 一貫性のない償還政策
• 市場に影響を与える主な要因

第5章 市場内訳：製品タイプ別

• 市場概要
• 人工内耳
• DBS
• DBSの承認済み適応症
• 膀胱・腸管制御インプラント
• 仙骨神経刺激装置 (SNS)
• 脛骨神経刺激装置 (TNS)
• 運動回復のための神経補綴
• 機能的電気刺激 (FES)
• ブレイン/コンピュータインターフェイス (BCI)
• 神経制御義肢
• 筋電プロテーゼ
• 脳制御義肢
• 義肢におけるBCI技術の現状
• その他
• 人工視覚・人工網膜
• 横隔膜ペーシングシステム/横隔神経刺激装置
• 市場収益：製品タイプ別
• 人工内耳
• 人工内耳：地域別収益
• 脳深部刺激装置 (DBS)
• DBS：地域別収益
• 運動回復のための神経補綴
• 運動回復のための神経補綴：地域別収益
• 膀胱・腸管制御インプラント
• 膀胱・腸制御インプラント：地域別収益
• その他
• その他：地域別収益

第6章 市場内訳：用途別

• 市場概要
• 神経系機能の代替
• 神経系の調節
• 市場収益：用途別
• 神経系機能の代替
• 市場収益：地域別
• 神経系の調節
• 市場収益：地域別

第7章 市場内訳：地域別

• 市場概要
• 市場収益：地域別
• 北米
• 欧州
• アジア太平洋
• その他の地域

第8章 ESGの展開

• ESG：イントロダクション
• 神経補綴 業界の持続可能性：ESGの視点
• ESGの主な課題
• 業界のESGパフォーマンス分析
• BCCによる総論

第9章 新興技術と開発

• 概要
• 脳制御義肢
• 感覚を備えたプロテーゼ
• AIを活用した神経補綴
• ネットワーク化された神経人工器官システム
• 小型デバイスと無線接続と給電

第10章 臨床試験

• 概要
• 人工内耳
• 運動回復のための神経補綴
• ブレインコンピューターインターフェイス (BCI)
• 機能的電気刺激 (FES)
• 脳深部刺激装置 (DBS)
• 膀胱・腸管制御インプラント
• その他

第11章 競合情報

• 概要
• 人工内耳
• 企業の市場シェア
• マーケットリーダーの製品ポートフォリオ
• 脳深部刺激装置 (DBS)
• 企業の市場シェア
• マーケットリーダーの製品ポートフォリオ
• 膀胱・腸管制御インプラント
• 企業の市場シェア
• マーケットリーダーの製品ポートフォリオ
• 運動回復のための神経補綴
• 主要企業の製品ポートフォリオ
• その他
• M&A

第12章 企業プロファイル

• ABBOTT LABORATORIES
• AXONICS INC.
• BIOVENTUS
• BLACKROCK NEUROTECH
• BOSTON SCIENTIFIC CORP.
• COCHLEAR LTD.
• CYBERDYNE INC.
• MED-EL MEDICAL ELECTRONICS
• MEDTRONIC
• NEUROPACE INC.
• PARADROMICS
• SONOVA
• SYNCHRON
• VIVANI MEDICAL INC.

第13章 付録

List of Tables

• Summary Table : Global Market for Neuroprosthetics, by Product Type, Through 2028
• Table 1 : Impairments Due to Dysfunction or Damaged Neurons
• Table 2 : U.S. FDA Device Classification of Neuroprosthetics
• Table 3 : Public Agency Funding/Initiatives, Neuroprosthetic Advancements
• Table 4 : Funds Raised, by Selected BCI Companies
• Table 5 : Factors Impacting Neuroprosthetics Market
• Table 6 : BCI Signal Acquisition Technologies
• Table 7 : BCI Industry Overview
• Table 8 : Motor Impairments and Prevalence
• Table 9 : Sensory Impairments and Prevalence
• Table 10 : Global Market for Neuroprosthetics, by Product Type, Through 2028
• Table 11 : Global Hearing Loss Prevalence, by WHO Region, 2019
• Table 12 : Global Market for Cochlear Implants, by Region, Through 2028
• Table 13 : Global Market for DBS, by Region, Through 2028
• Table 14 : Global Market for Neuroprosthetics for Movement Restoration, by Region, Through 2028
• Table 15 : Global Market for Bladder and Bowel Control Implants, by Region, Through 2028
• Table 16 : Global Market for Other Neuroprosthetics, by Region, Through 2028
• Table 17 : Global Market for Neuroprosthetics, by Application, Through 2028
• Table 18 : Global Market for Neuroprosthetics for Nervous System Function Replacement, by Region, Through 2028
• Table 19 : Global Market for Neuroprosthetics for Nervous System Modulation, by Region, Through 2028
• Table 20 : Global Market for Neuroprosthetics, by Region, Through 2028
• Table 21 : North American Market for Neuroprosthetics, by Product Type, Through 2028
• Table 22 : North American Market for Neuroprosthetics, by Application, Through 2028
• Table 23 : North American Market for Neuroprosthetics, by Country, Through 2028
• Table 24 : European Market for Neuroprosthetics, by Product Type, Through 2028
• Table 25 : European Market for Neuroprosthetics, by Application, Through 2028
• Table 26 : European Market for Neuroprosthetics, by Country, Through 2028
• Table 27 : Asia-Pacific Market for Neuroprosthetics, by Product Type, Through 2028
• Table 28 : Asia-Pacific Market for Neuroprosthetics, by Application, Through 2028
• Table 29 : Asia-Pacific Market for Neuroprosthetics, by Country, Through 2028
• Table 30 : RoW Market for Neuroprosthetics, by Product Type, Through 2028
• Table 31 : RoW Market for Neuroprosthetics, by Application, Through 2028
• Table 32 : Critical ESG Factors in Neuroprosthetics
• Table 33 : Major Neuroprosthetics Achievements: Key ESG Focus Areas
• Table 34 : ESG Rankings of Major Neuroprosthetics Companies, 2023*
• Table 35 : CDP Scope Card for Major Neuroprosthetics Companies, 2022
• Table 36 : Selected Significant Developments in BCI Technology
• Table 37 : Selected Cochlear Implants in Clinical Trial
• Table 38 : Selected BCI Neuroprosthetics in Clinical Trial
• Table 39 : Selected FES Neuroprosthetics in Clinical Trial
• Table 40 : Selected DBS in Clinical Trial
• Table 41 : Selected Bladder and Bowel Control Implants in Development
• Table 42 : Selected Visual Prosthetics in Development
• Table 43 : Market Leader Cochlear Implants Product Portfolio
• Table 44 : Currently Available: Deep Brain Stimulators (DBSs)
• Table 45 : Currently Available: Bladder and Bowel Control Implants
• Table 46 : Selected Neuroprosthetics for Movement Restoration
• Table 47 : Currently Available Diaphragm Pacing System
• Table 48 : M&A in the Neuroprosthetics Market Jan. 2021-May 2023
• Table 49 : Abbott Laboratories: Financials, 2022
• Table 50 : Abbott Laboratories: Neuroprosthetics Portfolio
• Table 51 : Abbott Laboratories: News/Key Developments, Jan 2021-June 2023
• Table 52 : Axonics Inc.: Financials, 2022
• Table 53 : Axonics Inc.: Neuroprosthetics Portfolio
• Table 54 : Axonics Inc.: News/Key Developments, Jan. 2022-June 2023
• Table 55 : Bioventus: Financials, 2022
• Table 56 : Bioventus: Neural Prosthetics Portfolio
• Table 57 : Bioventus: News/Key Developments, Jan. 2021-June 2023
• Table 58 : Blackrock Neurotech: Product Portfolio
• Table 59 : Blackrock Neurotech: News/Key Developments, Jan. 2021-June 2023
• Table 60 : Boston Scientific Corp.: Financials, 2022
• Table 61 : Boston Scientific Corp.: Neuroprosthetics Portfolio
• Table 62 : Boston Scientific Corp.: News/Key Developments, Jan. 2021-June 2023
• Table 63 : Cochlear Ltd.: Financials, 2022
• Table 64 : Cochlear Ltd.: Neural Prosthetics Portfolio
• Table 65 : Cochlear Ltd.: News/Key Developments, Jan. 2021-June 2023
• Table 66 : Cyberdyne Inc.: Financials, 2022*
• Table 67 : Cyberdyne Inc.: Neural Prosthetics Portfolio
• Table 68 : MED EL: Neuroprosthetics Portfolio
• Table 69 : Medtronic: Financials, 2022
• Table 70 : Medtronic: Neuroprosthetics Portfolio
• Table 71 : Medtronic: News/Key Developments, Jan. 2021-June 2023
• Table 72 : NeuroPace Inc.: Financials, 2022
• Table 73 : NeuroPace Inc.: Neuroprosthetic Portfolio
• Table 74 : NeuroPace Inc.: News/Key Developments, Jan. 2018-June 2023
• Table 75 : Paradromics: News/Key Developments, Dec. 2020-June 2023
• Table 76 : Sonova: Financials, 2022
• Table 77 : Sonova: Neural Prosthetics Portfolio
• Table 78 : Sonova: News/Key Developments, Dec. 2020-June 2023
• Table 79 : Synchron: News/Key Developments, Jan. 2020-June 2023
• Table 80 : Acronyms

List of Figures

• Summary Figure A : Global Market for Neuroprosthetics, by Product Type, 2020-2028
• Summary Figure B : Global Market Shares of Neuroprosthetics, by Product Type, 2022
• Figure 1 : Percentage of Disability, Adults 18+, U.S., 2019
• Figure 2 : Granted Breakthrough Device Designations (BDD), by Clinical Panel, As of March 31, 2023
• Figure 3 : DBS Primary Treatment: Patient Shares, by Indication
• Figure 4 : Leading Cause of Paralysis
• Figure 5 : Stroke and Associated Burden on Healthcare System in U.S., Europe and Canada
• Figure 6 : BCI Device Steps
• Figure 7 : BCI Signal Acquisition Technologies, by Type
• Figure 8 : Advantages of Brain-Controlled Prosthetic Limbs
• Figure 9 : Global Market for Neuroprosthetics, by Product Type, 2020-2028
• Figure 10 : Global Market Shares of Neuroprosthetics, by Product Type, 2022
• Figure 11 : Hearing Loss Prevalence, by Age Group, 2019
• Figure 12 : Global Market for Cochlear Implants, by Region, 2020-2028
• Figure 13 : Global Market Shares of Cochlear Implants, by Region, 2022
• Figure 14 : Global Market for DBS, by Region, 2020-2028
• Figure 15 : Global Market Shares of DBS, by Region, 2022
• Figure 16 : Global Market for Neuroprosthetics for Movement Restoration, by Region, 2020-2028
• Figure 17 : Global Market Shares of Neuroprosthetics for Movement Restoration, by Region, 2022
• Figure 18 : Global Market for Bladder and Bowel Control Implants, by Region, 2020-2028
• Figure 19 : Global Market Shares of Bladder and Bowel Control Implants, by Region, 2022
• Figure 20 : Global Market for Other Neuroprosthetics, by Region, 2020-2028
• Figure 21 : Global Market Shares of Other Neuroprosthetics, by Region, 2022
• Figure 22 : Global Market for Neuroprosthetics, by Application, 2020-2028
• Figure 23 : Global Market Shares of Neuroprosthetics, by Application, 2022
• Figure 24 : Global Market for Neuroprosthetics for Nervous System Function Replacement, by Region, 2020-2028
• Figure 25 : Global Market Shares of Neuroprosthetics for Nervous System Function Replacement, by Region, 2022
• Figure 26 : Global Market for Neuroprosthetics for Nervous System Modulation, by Region, 2020-2028
• Figure 27 : Global Market Shares of Neuroprosthetics for Nervous System Modulation, by Region, 2022
• Figure 28 : Global Market for Neuroprosthetics, by Region, 2020-2028
• Figure 29 : Global Market Shares of Neuroprosthetics, by Region, 2022
• Figure 30 : Investment on Grants for Biomedical Research, by Region, in 2020
• Figure 31 : North American Market for Neuroprosthetics, by Product Type, 2020-2028
• Figure 32 : North American Market Shares of Neuroprosthetics, by Product Type, 2022
• Figure 33 : North American Market for Neuroprosthetics, by Application, 2020-2028
• Figure 34 : North American Market Shares of Neuroprosthetics, by Application, 2022
• Figure 35 : North American Market for Neuroprosthetics, by Country, 2020-2028
• Figure 36 : European Market for Neuroprosthetics, by Product Type, 2020-2028
• Figure 37 : European Market Shares of Neuroprosthetics, by Product Type, 2022
• Figure 38 : European Market for Neuroprosthetics, by Application, 2020-2028
• Figure 39 : European Market Shares of Neuroprosthetics, by Application, 2022
• Figure 40 : European Market for Neuroprosthetics, by Country, 2020-2028
• Figure 41 : Global Aging (60+) Population, by Region, 2015-2050
• Figure 42 : Asia-Pacific Market for Neuroprosthetics, by Product Type, 2020-2028
• Figure 43 : Asia-Pacific Market Shares of Neuroprosthetics, by Product Type, 2022
• Figure 44 : Asia-Pacific Market for Neuroprosthetics, by Application, 2020-2028
• Figure 45 : Asia-Pacific Market Shares of Neuroprosthetics, by Application, 2022
• Figure 46 : Asia-Pacific Market for Neuroprosthetics, by Country, 2020-2028
• Figure 47 : RoW Market for Neuroprosthetics, by Product Type, 2020-2028
• Figure 48 : RoW Market Shares of Neuroprosthetics, by Product Type, 2022
• Figure 49 : RoW Market for Neuroprosthetics, by Application, 2020-2028
• Figure 50 : RoW Market Shares of Neuroprosthetics, by Application, 2022
• Figure 51 : Selected Factors Driving ESG
• Figure 52 : How A Strong ESG Proposition Benefits Business
• Figure 53 : Five Key ESG Focus Areas, Neuroprosthetics, 2022
• Figure 54 : Emerging Trends/Technologies in the Neuroprosthetics Market
• Figure 55 : Advantages of The Networked Neuroprosthetic (NNP) System
• Figure 56 : Principle Competitive Factors in the Neuroprosthetics Market
• Figure 57 : Global Market Shares of Cochlear Implants, by Manufacturer, 2022
• Figure 58 : Global Market Shares of DBS, by Manufacturer, 2022
• Figure 59 : Global Market Shares of Bladder and Bowel Control Implants, by Manufacturer, 2022
• Figure 60 : Abbott Laboratories: Financials, 2021 and 2022
• Figure 61 : Abbott Laboratories: Revenue Shares, by Business Unit, 2022
• Figure 62 : Abbott Laboratories: Revenue Shares, by Region, 2022
• Figure 63 : Axonics Inc.: Financials, 2021 and 2022
• Figure 64 : Axonics Inc.: Revenue Shares, by Product, 2022
• Figure 65 : Axonics Inc.: Revenue Shares, by Region, 2022
• Figure 66 : Bioventus: Financials, 2021 and 2022
• Figure 67 : Bioventus: Revenue Shares, by Business Unit, 2022
• Figure 68 : Bioventus: Revenue Shares, by Region, 2022
• Figure 69 : Boston Scientific Corp.: Financials, 2021 and 2022
• Figure 70 : Boston Scientific Corp.: Revenue Shares, by Business Unit, 2022
• Figure 71 : Boston Scientific Corp.: Revenue Shares, by Region, 2022
• Figure 72 : Cochlear Ltd.: Financials, 2021 and 2022
• Figure 73 : Cochlear Ltd.: Revenue Shares, by Business Segment, 2022
• Figure 74 : Cochlear Ltd.: Revenue Shares, by Region, 2022
• Figure 75 : Cyberdyne Inc.: Financials, 2021 and 2022
• Figure 76 : Cyberdyne Inc.: Revenue Shares, by Business Type, 2022
• Figure 77 : Cyberdyne Inc.: Revenue Shares, by Region, 2022
• Figure 78 : Medtronic: Financials, 2021 and 2022
• Figure 79 : Medtronic: Revenue Shares, by Business Unit, 2022
• Figure 80 : Medtronic: Revenue Shares, by Region, 2022
• Figure 81 : NeuroPace Inc.: Financials, 2021 and 2022
• Figure 82 : Sonova: Financials, 2021 and 2022
• Figure 83 : Sonova: Revenue Shares, by Business Unit, 2022
• Figure 84 : Sonova: Revenue Shares, by Region, 2022

Highlights:

The global neuroprosthetics market reached $5.0 billion in 2022, should reach $5.4 billion by 2023 and $8.1 billion by 2028 with a compound annual growth rate (CAGR) of 8.3% during the forecast period of 2023-2028.

Cochlear implants segment of the global neuroprosthetics market reached $1.5 billion in 2022, should reach $1.6 billion by 2023 and $2.1 billion by 2028 with a CAGR of 5.2% during the forecast period of 2023-2028.

Bladder and bowel control implants segment of the global neuroprosthetics market reached $967.7 million in 2022, should reach $1.1 billion by 2023 and $1.9 billion by 2028 with a CAGR of 11.6% during the forecast period of 2023-2028.

Report Scope:

This research study aims to thoroughly assess and analyze the neuroprosthetics market, revenue forecasts and future trends, globally, and to provide strategic recommendations for the success of market participants. The scope of the study is global. Current and projected market forecasts during the forecast period (2023 to 2028) are discussed. Figures for 2023 are estimated, except where actual results have been reported. This report includes forecasts by product type, application and region from 2023 through 2028.

This report also includes an analysis of leading and emerging competitors in the worldwide neuroprosthetics market. Profiles of leading product manufacturers and emerging players with novel products in development are also analyzed. This report assesses companies poised to introduce products during the forecast period and discusses how these introductions will change the face of the competitive environment.

Report Includes:

• 32 data tables and 49 additional tables
• A comprehensive overview and an up-to-date analysis of the global market for Neuroprosthetics
• Analyses of the global market trends, with historical market revenue data (sales figures) for 2022, estimates for 2023, forecasts for 2024 and 2026, and projections of compound annual growth rates (CAGRs) through 2028
• Estimation of the actual market size and revenue forecast for global neuroprosthetics market in USD million values, and corresponding market share analysis based on product, type of stimulation technology, application, and region
• In-depth information (facts and figures) concerning the major factors influencing the progress of this market (benefits, and industry-specific challenges) with respect to specific growth trends, upcoming technologies, future prospects, and contributions to the overall market
• Discussion of ESG developments in Neuroprosthetics market, and an understanding of the importance of ESG, consumer attitudes towards sustainability, risks and opportunity assessment, and ESG followed practices by product manufacturers and industry participants
• A relevant patent analysis with significant allotments of key patent grants on Neuroprosthetics
• Review of the recent merger and acquisition (M&A) activities, venture fundings, and other impactful strategies contributing to the growth of this market
• Identification of leading and emerging competitors in the worldwide neuroprosthetics market, and analysis of competitive landscape based on recent developments, segmental revenues, and operational integration
• Company profiles of major players within the industry, including Abbott Laboratories, Boston Scientific Corp., Cochlear Ltd., Medtronic, and Sonova

Table of Contents

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• Scope of Report
• Methodology and Information Sources
• Geographic Breakdown

Chapter 2 Summary and Highlights

• Market Outlook
• Market Summary

Chapter 3 Market Overview

• Overview and Definitions
• Neuroprosthetics
• Need for Neuroprosthetics
• Types of Neuroprosthetics
• Cochlear Implants
• Neuroprosthetics for Movement Restoration
• Deep Brain Stimulators (DBS)
• Bladder and Bowel Control Implants
• Visual Prosthetics
• Regulatory Landscape
• U.S.
• Europe

Chapter 4 Market Dynamics

• Drivers
• Favorable Demographic Trends
• Technological Advancements
• Support from Regulatory Agencies
• Increasing Pressure to Cut Costs
• Robust Funding Environment for Biomedical Research
• Unpenetrated Market
• Challenges
• High Cost
• Technological Challenges
• Safety Concerns
• Privacy and Accountability Concerns
• Inconsistent Reimbursement Policies
• Key Factors Impacting Market

Chapter 5 Market Breakdown by Product Type

• Market Overview
• Cochlear Implants
• Deep Brain Stimulators
• Approved Indications for Deep Brain Stimulation Therapy
• Bladder and Bowel Control Implants
• Sacral Nerve Stimulators (SNSs)
• Tibial Nerve Stimulators (TNSs)
• Neuroprosthetics for Movement Restoration
• Neuroprosthetics for Movement Restoration
• Functional Electrical Stimulation (FES)
• Brain/Computer Interface (BCI)
• Neural-controlled Prosthetic Limbs
• Myoelectric Prostheses
• Brain-controlled Prosthetic Limbs
• Current State of BCI Technology in Prosthetics
• Others
• Visual Prosthetics/Retinal Prosthetics
• Diaphragm Pacing System/Phrenic Nerve Stimulator
• Market Revenue by Product Type
• Cochlear Implants
• Cochlear Implants Market Revenue by Region
• Deep Brain Stimulators (DBS)
• DBS Market Revenue by Region
• Neuroprosthetics for Movement Restoration
• Neuroprosthetics for Movement Restoration Market Revenue by Region
• Bladder and Bowel Control Implants
• Bladder and Bowel Control Implants: Market Revenue by Region
• Others
• Others Market Revenue by Region

Chapter 6 Market Breakdown by Application

• Market Overview
• Nervous System Function Replacement
• Nervous System Modulation
• Market Revenue by Application
• Nervous System Function Replacement
• Market Revenue by Region
• Nervous System Modulation
• Market Revenue by Region

Chapter 7 Market Breakdown by Region

• Market Overview
• Market Revenue by Region
• North America
• Reimbursement and Insurance Coverage
• Innovation Hub and Robust Funding
• Encouraging Regulatory Environment
• Market Demand and Adoption
• Market Revenue by Product Type
• Market Revenue by Application
• Market Revenue by Country
• Europe
• Market Revenue by Product Type
• Market Revenue by Application
• Market Revenue by Country
• Asia-Pacific
• Market Revenue by Product Type
• Market Revenue by Application
• Market Revenue by Country
• Rest of the World (RoW)
• Market Revenue by Product Type
• Market Revenue by Application

Chapter 8 ESG Development

• Introduction to ESG
• Sustainability in the Neuroprosthetics Industry: An ESG Perspective
• Key ESG Issues
• Industry ESG Performance Analysis
• Concluding Remarks from BCC

Chapter 9 Emerging Technologies and Development

• Overview
• Brain Controlled Prosthetics
• Prosthesis with Sensations
• Artificial Intelligence (AI) Powered Neuroprosthetics
• Networked Neuroprosthesis System
• Miniaturized Devices and Wireless Connectivity and Powering

Chapter 10 Clinical Trials

• Overview
• Cochlear Implants
• Neuroprosthetics for Movement Restoration
• Brain Computer Interface (BCI)
• Functional Electrical Stimulation (FES)
• Deep Brain Stimulators (DBS)
• Bladder and Bowel Control Implants
• Others

Chapter 11 Competitive Intelligence

• Overview
• Cochlear Implants
• Company Market Shares
• Market Leader Product Portfolio
• Deep Brain Stimulators (DBS)
• Company Market Shares
• Market Leader Product Portfolio
• Bladder and Bowel Control Implants
• Company Market Shares
• Market Leader Product Portfolio
• Neuroprosthetics for Movement Restoration
• Key Companies Product Portfolio
• Others
• Mergers and Acquisitions (M&A)

Chapter 12 Company Profiles

• ABBOTT LABORATORIES
• AXONICS INC.
• BIOVENTUS
• BLACKROCK NEUROTECH
• BOSTON SCIENTIFIC CORP.
• COCHLEAR LTD.
• CYBERDYNE INC.
• MED-EL MEDICAL ELECTRONICS
• MEDTRONIC
• NEUROPACE INC.
• PARADROMICS
• SONOVA
• SYNCHRON
• VIVANI MEDICAL INC.

Chapter 13 Appendix